Aligos Therapeutics (ALGS) Stock Chart & Stock Price History $11.44 +1.16 (+11.28%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$11.37 -0.07 (-0.61%) As of 03/14/2025 06:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Aligos Therapeutics Stock Price Performance 5 Day Performance+8.85%1 Month Performance-51.67%3 Month Performance-66.01%6 Month Performance-19.55%Year-To-Date Performance-71.29%1 Year Performance-50.34% Receive ALGS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aligos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Remove Ads ALGS Stock Chart for Sunday, March, 16, 2025 ALGS Chart by TradingViewRemove Ads Aligos Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/14/2025$10.28$11.44+11.28%$11.76$10.62137,730 shs$41.05 million03/13/2025$10.81$10.28-4.90%$10.85$9.70138,861 shs$36.89 million03/12/2025$10.51$10.81+2.85%$11.17$10.19171,820 shs$38.79 million03/11/2025$10.41$10.51+0.96%$10.80$9.67153,465 shs$37.71 million03/10/2025$12.94$10.41-19.55%$12.49$9.51347,670 shs$37.35 million03/07/2025$13.48$12.94-4.01%$13.41$11.91260,296 shs$46.43 million03/06/2025$14.40$13.48-6.39%$14.43$13.39119,468 shs$48.37 million03/05/2025$14.34$14.40+0.42%$14.52$13.71116,613 shs$51.67 million03/04/2025$14.50$14.34-1.10%$14.60$12.76251,057 shs$51.45 million03/03/2025$16.87$14.50-14.05%$17.25$14.17206,855 shs$52.03 million Get the Latest News and Ratings for ALGS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aligos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 02/28/2025$16.76$16.87+0.66%$17.39$15.88134,098 shs$60.53 million02/27/2025$17.75$16.76-5.58%$18.61$16.60183,507 shs$60.14 million02/26/2025$17.33$17.75+2.42%$18.75$17.39268,671 shs$63.69 million02/25/2025$17.82$17.33-2.75%$17.89$16.02275,729 shs$62.18 million02/24/2025$18.63$17.82-4.35%$18.99$17.17291,612 shs$63.97 million02/21/2025$20.85$18.63-10.65%$21.88$18.13338,265 shs$66.84 million02/20/2025$22.28$20.85-6.42%$22.40$20.51138,995 shs$74.85 million02/19/2025$22.79$22.28-2.24%$23.13$21.61114,252 shs$79.99 million02/18/2025$23.67$22.79-3.72%$24.33$22.48130,243 shs$81.82 million02/17/2025$23.67$23.67$23.73$20.54304,878 shs$84.98 million Related Companies ProQR Therapeutics Stock Chart Eupraxia Pharmaceuticals Stock Chart Nanobiotix Stock Chart scPharmaceuticals Stock Chart 2seventy bio Stock Chart Enanta Pharmaceuticals Stock Chart Actuate Therapeutics Stock Chart Compugen Stock Chart MacroGenics Stock Chart Inhibikase Therapeutics Stock Chart Receive ALGS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aligos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALGS) was last updated on 3/16/2025 by MarketBeat.com Staff From Our PartnersNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | Sponsored[Revealed] Trump’s Plan to Protect Your Savings for the Deep StateDuring Trump's first term, gold skyrocketed 52.89%. And it's already surging before his second. Last yea...Genesis Gold Group | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredOur #1 Defense Stock for MarchChina just deepened its military alliance with America's enemies in the Middle East... By conducting joint ...Behind the Markets | SponsoredIs 2025 really the best time to get rich in American history?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aligos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aligos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALGS Stock Alerts